Simplifying Global Compliance
View Archived Issues
October 2019
No. 477
Headlines
Full Issue of The GMP Letter in PDF Format
Download and view the full issue. Read More
FDA’s Top Ten GMP Citations for FY 2019
An FDAnews analysis of the FDA’s Form 483 inspection reports for fiscal year 2019 shows devicemakers continue to be tripped up at the same old hurdles. Read More
EC Releases Guidelines on Benefit-Risk Analysis for Phthalates
The European Commission released final guidelines for devicemakers, notified bodies and regulators on how to perform a benefit-risk analysis for phthalates in medical devices. Read More
FDA Pilots Accreditation Scheme for Conformity Assessment
The FDA is establishing a pilot accreditation scheme for conformity assessment (ASCA) whereby testing laboratories may be accredited by accreditation bodies to assess the conformance of a device within certain FDA-recognized standards. Read More
FDA Issues Warning to Indiana Devicemaker
The FDA issued a warning letter to Polymer Technology Systems — doing business as PTS Diagnostics — arising from an inspection earlier this year of its facility in Indianapolis. Read More
FDA Creates New Safer Technologies Program
The FDA is introducing a new review program for certain medical devices and device-led combination products that are expected to significantly improve the safety of treatments for a disease or condition deemed less serious than those eligible for the breakthrough devices program. Read More
483 Roundup: FDA Hits Six Firms for Quality Management Lapses
The FDA cited six devicemakers for a variety of quality problems uncovered during the agency’s inspections of their facilities. Read More
IMDRF Flags Lack of ‘Global Alignment’ in Cybersecurity
Devicemakers should assess cybersecurity risks throughout the product lifecycle, the International Medical Device Regulators Forum (IMDRF) says, in a new draft guidance that calls for “convergence of global healthcare cybersecurity principles and practices.” Read More
